Abstract
Tumor necrosis factor (TNF) antagonists are biologic response modifiers that have significantly improved the outcomes in patients with rheumatoid arthritis (RA). At this report, safety data were collected on approximately 271,000 patients administered infliximab (as of February 2002), 121,000 patients administered etanercept (as of December 2001), and on 2400 patients who received adalimumab in trials in connection with the regulatory approval process (approval granted December 2002 in the US and September 2003 in European Union). Infliximab and etanercept have predictable and manageable safety profiles, and preliminary data suggest that the profile of adalimumab is comparable. Safety issues involving the anti-TNF agents as a class include the risk of injection-site reactions or infusion-related reactions, infection (for example, serious, opportunistic, or tubercular), malignancy, autoimmunity, and demyelinating and neurologic disorders. Injection-site and infusion-related reactions are most often easily managed and rarely lead to discontinuation of therapy. Infections can be minimized or prevented by screening and careful monitoring and follow-up; most infections respond to appropriate medical treatment. More studies are neede...Continue Reading
References
Aug 1, 1991·Arthritis and Rheumatism·M E JeurissenW H Muller
Feb 17, 1993·Journal of the National Cancer Institute·G GridleyJ F Fraumeni
Jan 1, 1996·Rheumatology International·A SchnabelW L Gross
Aug 1, 1996·British Journal of Rheumatology·M JonesF Wolfe
Nov 14, 1997·Immunology Today·A EiglerS Endres
Oct 12, 1999·JAMA : the Journal of the American Medical Association·C DyeM C Raviglione
Dec 22, 1999·Alimentary Pharmacology & Therapeutics·S B Hanauer
Jan 6, 2000·Lancet·R MainiP Lipsky
Mar 7, 2000·Lancet·F C Breedveld
Oct 31, 2000·International Journal of Cancer. Journal International Du Cancer·E ThomasG J Macfarlane
Nov 7, 2000·Journal of Pharmaceutical Sciences·S Porter
Nov 30, 2000·The New England Journal of Medicine·P E LipskyUNKNOWN Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group
Jun 9, 2001·Rheumatic Diseases Clinics of North America·E C Keystone
Dec 12, 2001·JAMA : the Journal of the American Medical Association·D S Pisetsky, E W St Clair
Jul 13, 2002·Arthritis and Rheumatism·E William St ClairEdward C Keystone
Oct 2, 2002·Arthritis and Rheumatism·Michele F DoranSherine E Gabriel
Oct 18, 2002·Arthritis and Rheumatism·Jong-Hoon LeeM Miles Braun
Jun 24, 2003·The American Journal of Gastroenterology·Adam CheifetzScott Plevy
Citations
Mar 25, 2008·Therapeutics and Clinical Risk Management·Kim A Papp
Mar 8, 2006·Clinical Rheumatology·Masahide HamaguchiToshikazu Yoshikawa
Feb 4, 2005·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·K Greiner, J Plskova
May 19, 2010·Expert Review of Clinical Immunology·Danial E Baker
Dec 18, 2010·Expert Review of Clinical Immunology·Enrico MaggiAndrea Matucci
Mar 1, 2008·Expert Opinion on Drug Discovery·Marcus D Köller
Mar 26, 2005·Immunological Reviews·Jörg J Goronzy, Cornelia M Weyand
May 13, 2005·The British Journal of Dermatology·D HircheS A Eming
Jun 27, 2006·International Journal of Dermatology·Patricia T Ting, John Y Koo
May 23, 2006·Cytokine·Fanny Baran-MarszakMartine Raphaël
Nov 17, 2005·Rheumatic Diseases Clinics of North America·Jeska K de Vries-BouwstraFerdinand C Breedveld
Dec 1, 2017·Ophthalmology and Therapy·Srilakshmi M SharmaKanmin Xue
Jun 15, 2006·Nature Reviews. Drug Discovery·Luke A J O'Neill
Aug 10, 2006·Rheumatology International·N Inanc, H Direskeneli
Nov 24, 2006·Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society·Linda Leff
Jan 18, 2007·Pediatric Emergency Care·Bridgette GuthrieSally L Reynolds
Feb 5, 2008·British Journal of Pharmacology·S G Ward
Oct 9, 2007·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Magdalena DziadzioClare Higgens
Jul 18, 2008·Acta Ophthalmologica·Sven SahlinAbiel Orrego
Jun 30, 2005·Arthritis and Rheumatism·Leen De RyckeFilip De Keyser
Sep 9, 2005·Medicine·Nancy F CrumMark R Wallace
Feb 4, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Neil H Shear
Aug 12, 2020·Clinical Drug Investigation·Najat J ZiyadehJohn D Seeger
Aug 2, 2018·Therapeutic Advances in Chronic Disease·Paul Sator
Jun 10, 2021·Open Access Rheumatology : Research and Reviews·Eduardo MyslerAna Lizarraga
Jun 26, 2021·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Veranika SasnovskayaAimee Chevalier
Jul 20, 2016·Pediatrics·H Dele Davies, UNKNOWN COMMITTEE ON INFECTIOUS DISEASES